
Wednesday, February 27, 2008
Ayurvedic Herb Kills Cancer Cells

CANCER FOUNDATIONS
Wednesday, February 20, 2008
Boston Lawyer Michael Shepard Taking Mesothelioma, Personal Injury, Asbestos Cases
Michael Shepard has an established reputation of being a compassionate attorney who, along with mesothelioma and asbestos related injuries, also helps people in their pain and suffering arising out of injuries inflicted to them due to the faults of others. If people are injured due to exposure to toxic chemicals, product defects, nursing home negligence, silica, talc, welding fumes automotive or aviation accidents, they should contact the attorneys office to seek guidance for obtaining compensation for the injury caused.
In his website, the mesothelioma cancer lawyer acknowledges that the time of the injured is precious and says “We know our clients want the freedom to see family and friends whenever they choose. We also know that because of their condition, they don’t want to be bogged down in legal matters. Through years of experience in this field, we have developed a streamlined approach to handling asbestos-related litigation that lessens the amount of time our clients spend dealing with lawyers and the courts. After a client’s brief, free, one-on-one consultation with us, we take the matter into our own hands, independently investigating the specific facts of the case, collecting crucial evidence and confronting the people who are responsible for your illness or injury. We make every effort to transform our clients’ “good” case into a “great” case that may secure the maximum compensation deserved.”
Whether the injured is in Boston, Vermont, New Hampshire or Rhode Island, Boston Mesothelioma cancer lawyers are ready to look into the case and assess the maximum compensation during the first free one to one consultation.
Source
Thursday, February 14, 2008
Epithelial Mesothelioma
Although reported incidence rates have increased in the past 20 years, epithelial mesothelioma is still a relatively rare cancer. Incidence of malignant epithelial mesothelioma currently ranges from about 7 to 40 per 1,000,000 in industrialized Western nations, depending on the amount of asbestos exposure of the populations during the past several decades. More than 500,000 asbestos or mesothelioma lawsuits have been filed against asbestos manufacturers and employers, for neglecting to implement safety measures after the links between asbestos, asbestosis, and mesothelioma became known.
Although epithelial mesothelioma is generally resistant to curative treatment with radiotherapy alone, it is often used to make the person with cancer comfortable or to relieve symptoms arising from tumor growth, such as obstruction of a major blood vessel. Radiation therapy alone has never been shown to improve survival from epithelial mesothelioma. In fact, the necessary radiation dose to treat mesothelioma that has not been surgically removed would be very toxic.
About the Author
James Howell is a freelance writer and researcher. Find out more about
Epithelial Mesothelioma.
Tuesday, February 12, 2008
How to overcome depression
How to overcome depression
Modern life is becoming faster and faster. Every day we have to solve different problems and meet many people just because you do not want to leg behind the pace of life or just earn money for a living.
Of course we like our job but one day your boss can give you the most difficult task which you will not be able to complete at once and as a result you can be so depressed to do anything at all. And of course, you will need depression help but it is not very easy. Some people start drinking a lot of alcohol or even use drugs. But it is not a way out because it can only make the situation worse. Only specialists can help because a depressed person already is in a situation where he does not see solutions of his problems. In this case guided meditation can become a useful tool because a specialist can teach a person to overcome all his problems himself. This effect is achieved with the help of meditation using special words and of course special music. This method is very effective and was used for a long time and proved to be very effective.
Sunday, January 27, 2008
Asbestos victims’ drug hope
VICTIMS of York's asbestos timebomb have been given a major boost after a medicine rationing organisation ruled they are entitled to a vital drug.
The National Institute for Clinical Excellence (NICE) has decided the drug Alimta should be made available to patients with the asbestos-related cancer mesothelioma.
The York Asbestos Support Group today hailed the decision, saying that while the drug was not a cure, it could both extend life and alleviate symptoms for patients and was the only treatment available.
"The NICE decision brings to a conclusion an approval process which started almost three years ago and which led to one of the worst examples of the health postcode lottery," said the group's delighted founder Kim Daniells.
"Hundreds of patients across the UK were refused treatment with this drug whilst those in Scotland, the North West and North East of England could access treatment."
She said NICE had rejected an appeal against an original decision to approve the use of the drug for the treatment of the condition, which was a fatal tumour of the lung pleura caused by exposure to asbestos.
"In the last three years, many hundreds of patients have been diagnosed with the condition and gone on to die without ever being able to access the treatment. Hopefully this situation will now come to an end."
She said NICE's guidance meant primary care trusts would now be obliged to provide uniform treatment.
They would be given the option of a 90-day lead-in period following the official announcement, but she hoped the guidance would result in mesothelioma sufferers gaining prompt access to the treatment they needed and deserved.
The decision could benefit former York Carriageworks employees who fall victim in future to mesothelioma.
Staff were widely exposed to deadly asbestos dust fibres during the 1950s, 1960s and 1970s, and even in the 1980s after some measures had been brought in to provide protection to staff.
Scores of ex-workers have died from the devastating cancer.
A NICE spokesman said Alimta was being recommended as a possible treatment for malignant pleural mesothelioma in people with advanced disease, and whose cancer was not suitable for surgical removal and who met certain other conditions.
Wednesday, January 23, 2008
Alfacell Signs Onconase Purchase And Supply Deal With Scientific Protein Labs [ACEL]
Onconase, the company's lead drug candidate, is currently being evaluated as a treatment for unresectable malignant mesothelioma or UMM in a confirmatory Phase IIIb clinical trial.
Kuslima Shogen, chief executive officer of Alfacell, said, “We have been pleased with the superb performance of the extremely well qualified team at SPL for many years and are confident that the commercial production of ONCONASE is in the right hands. This agreement is another step forward for Alfacell as we plan for the commercialization of ONCONASE.”
Onconase is a first-in-class product candidate from Alfacell's proprietary ribonuclease or RNase technology.
In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of Onconase in non-small cell lung cancer or NSCLC and other solid tumors.
ACEL is currently trading at $2.40, up 16 cents or 6.95%.
Source